UVC LED disinfection respirator

We believe we share mutual goals of improving well being around the world, which is particularly vital nowadays due to the Covid-19 pandemic outbreak. Anti-microbial  respirators will utilize  ultraviolet radiation of innovative UV LEDs to sterilize inhaled air  and provide the disinfection level up to 99.9%. Apart from protecting healthy users from inhaling air contaminated by pathogens, these respirators can also be used to disinfect air exhaled by an infected individual. We are confident that using modern UV LEDs, it is possible to develop and organize the production of sterilizing anti-microbial respirators to protect physicians and other employees at increased risk of infection.

For control of new viral infectious diseases universally recognized strategy is the development of a vaccine with subsequent mass production and massive vaccination campaign.  This strategy has the timing problem – at the initial period of disease spread the vaccine is not-available and the development and testing of safe vaccine could require from one to two years.  For viruses with large coefficient of spread R > 1 and large mortality and/or symptoms requiring long hospitalization and use of complex medical facilities this initial absence of vaccine requires the search for other strategies effectively working in this initial period. 

We suggest this alternative strategy which would work in the early stages of a potential pandemic threat caused by a new virus.  The suggested strategy using innovative personal protective equipment which would not demand strong change in the individual behavior, prevent spread of the infection  in an early stage of generalized epidemic.

The mass use of such innovative respirator combined with the implementation of the relevant behavior mode can reduce basic reproductive ratio significantly less than 1 and therefore reverse the growth of the epidemic of viral disease at an early stage.

Anti-microbial respirator consists of a mask/respirator connected by a tube with air ducts with a small remote module attached to the belt with an active air disinfection system through exposure of UV radiation and a built-in battery. The device will utilize ultraviolet radiation of innovative UV LEDs with a wavelength of 278 nm to sterilize inhaled air and provide the disinfection level up to 99.9%. The concept provides a number of innovative solutions that significantly increase the energy efficiency of the device while maintaining its high disinfection efficiency. This is very important, because the device has autonomous power supply.

We are confident that using modern UV LEDs, it is possible to develop and organize the production of sterilizing anti-microbial respirators to protect physicians and other employees at increased risk of infection. Specifically, we are talking about a potential invention that could change the course of this and highly likely other airborne diseases and significantly contribute to making it safer for people around the world. We plan to deliver a reliable, compact, and convenient UV disinfecting respirator.

This innovation is designed to save lives of medical professionals, police officers, couriers and other people who may be significantly exposed to the virus due to the nature of their profession or a job.

 In the early stages of a potential pandemic threat caused by a new virus, which is transferred from person to person mainly by breathing and touching the face by contaminated hands.  The suggested strategy using our respirators prevent spread of the infection in an early stage of generalized epidemic without quarantine actions.

Today, the whole world is in deficit of masks, respirators and such protection for doctors. Easy to use, quite comfortable reusable reliable personal protective equipment should be required by the market. There’s no other tool like active UVC respirators on the market today. 

The method of using UVC radiation from a germicidal lamp to deactivate viruses is widely used indoors. UVC LED production is a relatively new segment, and their use for decontamination of the necessary airflow for breathing does not currently have the correct technical solutions. We know the solution and how this can be done.

There’s no other tool like active UVC respirators on the market today.

The method of using UVC radiation from a germicidal lamp to deactivate viruses is widely used indoors. UVC LED production is a relatively new segment, and their use for decontamination of the necessary airflow for breathing does not currently have the correct technical solutions.

Unlike N95 respirators, our solution can be used for an unlimited time. In addition to the advantage of reusability, our solution wins according to the operating principle: instead of filtering the air, viruses are destroyed. The absence of a filter makes it easy to breathe through our device. Dirt along with pathogenic organisms accumulates on the filter of the N95 respirator, so it requires careful use during removal and subsequent destruction. Our solution does not have these problems.

We win compared to it by reusability, comfort during use, reliability and safety when using.

The proposed respirator has a disinfection chamber completely closed for the exit of UV radiation and does not generate ozone during operation, which makes it absolutely safe to use. The device will utilize ultraviolet radiation of innovative UV LEDs with a wavelength of 278 nm to sterilize inhaled air and provide the disinfection level up to 99.9%. The concept provides a number of innovative solutions that significantly increase the energy efficiency of the device while maintaining its high disinfection efficiency.

We have developed a design and calculated the characteristics of an active type independent power supply respirator designed to sterilize inhaled/exhaled air with an efficiency of 99.9%. 

Tests performance period requires negotiations with specialized laboratories.

We want to solve several challenges raised by pandemic:

1.Risk of infection Most At Risk Populations , mostly doctors. Convenient mask that can be used by both doctors and patients, designed to sterilize inhaled/exhaled air, safely secure them.

 2.Problems of the spread of infection and potential pandemic threat at an early stage.  The mass use of such innovative respirator can reduce basic reproductive ratio significantly less than 1 and therefore reverse the growth of the epidemic of viral disease at an early stage.

During the pandemic provide doctors and other healthcare workforce who are in a dangerous infectious area with reliable and convenient reusable protective equipment.

It is planned to develop and put into mass production a respirator intended for use by the general public in case of an adverse epidemiological situation.

Testing of disinfection prototype module (MVP model) in a virological laboratory to verify that a 99.9% disinfection level from viral infection can be reached. Examine the connection between the disinfection efficiency and the intensity of UVC radiation and the air flow rate (for 4 months). In the period up to 6 months, develop and launch an EVT, DVT disinfection module. Develop PVT module (8 months). Testing and certification. Mass production launch (1 year).

During the pandemic provide doctors and other healthcare workforce who are in a dangerous infectious area with reliable and convenient reusable protective equipment.

It is planned to develop and put into mass production a respirator intended for use by the general public in case of an adverse epidemiological situation.

 Significant funds allocated to the fight against a pandemic were being used primarily on the development of a vaccine, since vaccines prevent and save lifes from plague, smallpox and other terrible diseases.

 Other possible ways to prevent the spread of infectious diseases have not been taken into consideration by the experts and parties interested in fighting epidemics.

Funding and community support are needed.

We are looking for ways to widely inform and promote our solution.

Perhaps the MIT Solve community can help us.

The company constitutes the 8 experts in lighting development: electrical, optical and mechanical engineers, programmers, designers and business managers.

We also organize joint venture with the specialists from Creon2000.

We are experts in electronics, lighting engineering, and mechanical structures with over 20 years of experience in LED technology.

We are working with the www.creon2000.com, inventor of the UVC air purification technology. MARK GLAZMAN is the CEO and author of several patents of UV-C Light Irradiation. We cooperate in a joint venture format.

First of all, our UVC respirators designed for doctors and other people who may be significantly exposed to the virus due to the nature of their profession or a job.

Our business model - B2B sales to relevant organizations.

At the second stage of the project, it is possible to sell our respirators as a protective equipment of the population.

Business model can be both B2C sales and public procurement.

We think we can get funding through grants. After that we are ready to develop and organize mass production of anti-microbial respirators, a vital component of personal protective equipment.

We trust that the reputation of MIT Solve will allow us to expand informing about our project and achieve collaboration with virological laboratories.

We have our calculations and a prototype. However, we need to have independent experts to test the ratio and to provide us with the required scientific expertise regarding the features of Covid-19 that have to be taken into account when designing and manufacturing the described device. This expertise will substantially contribute to the project, and together we might achieve our goals.

We also expect that MIT Solve support will help with the financing of research and the subsequent stages of development of a UVC respirator

Partnership with MIT Solve will help us to better prepare pitch, business plan and other documents necessary for obtaining financing. We also hope for help in PR events.

We need help in organizing partnerships with virology laboratories for the research.

We are looking for Testing, Dependency testing for base parameters. Our partner will benefit in authorship of scientific works and could commercialize the continuation of research on the use and improvement of respiratory protection, to commercialize (earn) royalties on intellectual property.

Partnership goal is a creation of a qualitatively new breathing protection device from microbial contamination.  

MIT specialists to help prepare pitch, business plan and other documents necessary for finding financing.

Virology laboratories for organizing testing of our device.

The company constitutes the 8 experts in lighting development: electrical, optical and mechanical engineers, programmers, designers and business managers.

Testing of disinfection prototype module (MVP model) in a virological laboratory to verify that a 99.9% disinfection level from viral infection can be reached. Examine the connection between the disinfection efficiency and the intensity of UVC radiation and the air flow rate (for 4 months). In the period up to 6 months, develop and launch an EVT, DVT disinfection module. Develop PVT module (8 months). Testing and certification. Mass production launch (1 year).